Immediate Impact
13 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
The current landscape of the antimicrobial peptide melittin and its therapeutic potential
2024 Standout
Works of Laura Murillo being referenced
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial
2019
Phase III Study of Palbociclib in Combination with Exemestane Vs. Capecitabine, in Hormonal Receptor (Hr) Positive/Her2 Negative Metastatic Breast Cancer (Mbc) Patients with Resistance to Non-Steroidal Aromatase Inhibitors (Nsai): Pearl Study (Geicam/2013-02_Cecog/Bc.1.3.006)
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Laura Murillo | 45 | 20 | 17 | 14 | 59 | |
| Željko Soldić | 46 | 22 | 9 | 14 | 84 | |
| Jasmine C. Huynh | 44 | 21 | 10 | 13 | 88 | |
| Naoko Takebe | 37 | 18 | 13 | 17 | 79 | |
| Martina Di Trani | 23 | 12 | 19 | 9 | 59 | |
| Hayley McKenzie | 54 | 33 | 15 | 10 | 85 | |
| Edward Y. Zhu | 28 | 26 | 24 | 13 | 71 | |
| Marcelo Blaya | 37 | 30 | 16 | 15 | 78 | |
| Mohamed Elfagieh | 28 | 10 | 16 | 8 | 60 | |
| Yiu-Keung Lau | 26 | 19 | 9 | 10 | 51 | |
| Feng Xu | 20 | 14 | 10 | 17 | 60 |
All Works
Login with ORCID to disown or claim papers
Loading papers...